Fassan, Matteo http://orcid.org/0000-0001-6515-5482
Brignola, Stefano
Pennelli, Gianmaria
Alberti, Giulia
Angerilli, Valentina
Bressan, Alessandra
Pellino, Antonio
Lanza, Cristiano
Salmaso, Roberta
Lonardi, Sara
Pucciarelli, Salvatore
Spolverato, Gaya
Scarpa, Marco
Realdon, Stefano
Farinati, Fabio
Luchini, Claudio
Rugge, Massimo
Loupakis, Fotios
Funding for this research was provided by:
Università degli Studi di Padova (DOR)
Article History
Received: 29 July 2019
Revised: 10 October 2019
Accepted: 14 October 2019
First Online: 14 November 2019
Compliance with ethical standards
:
: Fotios Loupakis had roles as consultant or advisor for Roche, Bayer, Amgen, Genentech. Sara Lonardi had roles as consultant or advisor for Amgen, Bayer, Merck Serono, Lilly. She is part of speakers bureau of Lilly, and BMS. All the others authors declare no conflict of interest regarding the publication of this article.
: The study was approved by the local ethic committee.